LeMaitre Vascular Inc

NASDAQ:LMATUnited States

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

Contact Information

Headquarters

63 2nd AveBURLINGTON, MA, United States 01803-4413

Phone

781-221-2266

Fax

781-425-5049

Executives

Chairman of the Board, Chief Executive Officer

George LeMaitre

President, Director

David Roberts

Chief Financial Officer, Director

Joseph Pellegrino

Senior Vice President - Advanced Manufacturing Engineering

Ryan Connelly

Senior Vice President - Clinical, Regulatory, Quality Affairs

Andrew Hodgkinson